Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer

Journal of Pathology

Volumn 182, Issue 3, 1997, Pages 318-324

  Ropponen, Kirsi M ^a   Eskelinen, Matti J ^b   Lipponen, Pertti K ^a   Alhava, Esko ^b   Kosma, Veli Matti ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Colorectal cancer; Prognosis; Tumour infiltrating lymphocytes (TILs)

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; COLORECTAL CANCER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE TABLES; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS;

EID: 0030787373     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6     Document Type: Article

References (35)

1. Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 1986; 39: 585-589.
2. Svennevig JL, Lunde OC, Holter J, Bjorksvik D. Lymphoid infiltration and prognosis in colorectal carcinoma. Br J Cancer 1984; 49: 375-377.
3. Aaltomaa S, Lipponen PK, Eskelinen MJ, et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer 1992; 28: 859-864.
4. Furukawa T, Watanabe S, Kodama T, et al. T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis. Cancer 1985; 56: 2651-2656.
5. Tsujitani S, Furukawa T, Tamada R, et al. Langerhans cell and prognosis in patients with gastric carcinoma. Cancer 1987; 59: 501-505.
6. Clark WH, Elder DE, Guerry IV D, et al. Model predicting survival in stage I melanoma based on tumour progression. J Natl Cancer Inst 1989; 81: 1893-1904.
7. Clemente C, Mihm M, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 7: 1303-1310.
8. McCarty WG. Principles of prognosis in cancer. J Am Med Assoc 1931; 96: 30-33.
9. Zamcheck N, Doos WG, Prudente R, Lurie BB, Gottlieb LS. Prognostic factors in colon carcinoma. Correlation of serum carcinoembryonic antigen level and tumor histopathology. Hum Pathol 1975; 6: 31-45.
10. Watt AG, House AK. Colonic carcinoma. A quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis. Cancer 1978; 41: 279-282.
11. Thynne GS, Weiland LH, Moertel CG, Silvers A. Correlation of histopathologic characteristics of primary tumor and uninvolved regional nodes in Dukes' C colonie carcinoma with prognosis. Mayo Clin Proc 1980; 55: 243-245.
12. Carlon CA, Fabris G, Arslan-Pagnini C, Pluchinotta AM, Chinelli K, Carniato S. Prognostic correlations of operable carcinoma of the rectum. Dis Colon Rectum 1984; 28: 47-50.
13. Jass JR, Ajioka Y, Allen JP, et al. Assessment of invasive growth pattern and Iymphocytic infiltration in colorectal cancer. Histopathology 1996; 28: 543-548.
14. UICC. In: Hermannek P, Sobin LH, eds. TNM Classification of Malignant Tumours. 4th edn. Berlin: Springer-Verlag, 1987.
15. Turnbull RB, Kyle K, Watson FB, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967; 166: 400-427.
16. Lipponen P, Kosma V-M, Collan Y, Kulju T, Kosunen O, Eskelinen M. Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder. Eur Urol 1990; 17: 333-337.
17. Haapasalo H, Collan Y, Atkin NB, Pesonen E, Seppä A. Prognosis of ovarian carcinomas: prediction by histoquantitative methods. Histopathology 1989; 15: 167-178.
18. Eskelinen MJ, Lipponen PK, Papinaho S, et al. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Int J Cancer 1992; 51: 555-561.
19. Lee E, Desu M. A computer program for comparing k samples with right censored data. Comput Program Biomed 1972; 2: 315-320.
20. Cox DR. Regression models and life tables with discussion. J R Stat Soc B 1972; 34: 187-192.
21. Vesalainen S, Lipponen P, Talja M, Syrjänen K. Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994; 30A: 1797-1803.
22. Fossum B, Gedde-Dahl T III, Breivik J, et al. p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ T cells recognize a peptide corresponding to a common mutation (13 Gly to Asp). Int J Cancer 1994; 56: 40-45.
23. Meta M, Ponte M, Guastella M, et al. Detection of oligoclonal T lymphocytes in lymph nodes draining from advanced non-small-cell lung cancer. Cancer Immunol Immnunother 1995; 40: 35-40.
24. Di-Giorgio A, Botti C, Tocchi A, Mingazzini P, Flammia M. The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. Int Surg 1992; 77: 256-260.
25. Secco GB, Fardelli R, Campora E, et al. Prognostic value of the Jass histopathologic classification in left colon and rectal cancer: a multivariate analysis. Digestion 1990; 47: 71-80.
26. Kaklamanis L, Townsend A, Doussis-Anagnostopoulou IA, Mortensen N, Harris AL, Gatter KC. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 1994; 145: 505-509.
27. Kammerer R, von Kleist S. CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-cell lysis. Int J Cancer 1994; 57: 341-347.
28. Hom S, Rosenberg S, Topalian S. Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion. Cancer Immunol Immunother 1993; 36: 1-8.
29. Barth R, Camp B, Martuscello T, Dain B, Memoli V. The cytokine microenvironment of human colon carcinoma. Cancer 1996; 6: 1168-1178.
30. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148-156.
31. Lothe RA, Peltomäki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849-5852.
32. Jass JR, Cottier DS, Jeevaratnam P, et al. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 1995; 346: 1200-1201.
33. Riethmuller G, Schneider-Gadicke E, Schlimok G, et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-lA Study Group. Lancet 1994; 343: 1177-1183.
34. Sinicrope FA, Sugarman SM. Role of adjuvant therapy in surgically resected colorectal carcinoma. Gastroenterology 1995; 109: 984-993.
35. Lygidakis NJ, Ziras N, Parissis J. Resection versus resection combined with adjuvant pre-and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 1995; 42: 155-161.